Purchase Order 75N95023P00384
Award Date
6/22/23
Potential Completion Date
7/20/23
Potential Value
$39K
Funding Federal Agency
National Center for Advancing Translational Sciences
Contracting Federal Agency
National Institute on Drug Abuse
Awardee
Promega Corporation
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Madison, WI 53711, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This firm-fixed-price purchase order was awarded to Promega Corporation, a global life sciences company, by the National Center for Advancing Translational Sciences (NCATS) within the Department of Health and Human Services' National Institutes of Health. The $121,492.50 contract is for the procurement of detection assay systems with an August 2021 completion date. Promega has previously been awarded prime and subcontracts by various agencies including the NIH, CDC, DoD, and FBI to provide DNA...
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) on behalf of the National Center for Advancing Translational Sciences (NCATS) to Promega Corporation, a global life sciences company. The $83,800 contract is for the procurement of Promega reagents and assays to support NCATS' Antiviral Program for Pandemics. The award does not utilize a set-aside designation. The original solicitation states that NCATS' screening assays have been optimized using Promega...
This firm fixed-price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation, a global life sciences company based in Madison, Wisconsin. The contract, valued at $79,736.40, is for the delivery of a LUCIFERASE 1000 ASSAY (AMBIS #1676428) product from Promega. This award does not utilize any set-aside designation. Promega is a major supplier of specialized laboratory equipment,...
This federal contract award was issued by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation, a global life sciences company based in Madison, Wisconsin. The award, valued at $19,874.40, is for the procurement of 26 units of the LUCIFERASE 1000 REAGENT, Catalog # E4550, at $382.20 per unit. This is a Firm Fixed Price Blanket Purchase Agreement (BPA) call order with a completion date of March 8, 2012....
This is a $83,800 firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Promega Corporation. The award is to procure custom Promega assays and reagents, including the MTase-Glo Methyltransferase Assay, to support NCATS's Antiviral Program for Pandemics. The award is non-competitive as Promega's reagents are specifically engineered and optimized for NCATS's high-throughput screening and...
The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences awarded a firm fixed price purchase order contract to Promega Corporation, a global life sciences company, for the provision of reagent kits and assays. The contract has a potential value of $22,784.00 and a completion date of July 21, 2020. Promega has previously provided DNA analysis equipment, reagents, assays, and related laboratory supplies to federal agencies...
This is a $13,289.40 firm fixed price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Promega Corporation for the purchase of luciferase reagents. The contract has an ultimate completion date of April 11, 2014 and does not utilize any set-aside designations. Promega Corporation is a global life sciences company that provides a wide range of products and services to support biomedical...
The Department of Health and Human Services' National Institutes of Health National Center for Advancing Translational Sciences awarded a $24,294.20 firm fixed price purchase order to Promega Corporation for CASPASE-GLO(R) 3/7 ASSAY, 100ML. The contract has a completion date of September 8, 2023 and was awarded on August 18, 2023. This order is not associated with a set-aside program. Promega Corporation is a global life sciences company that provides various biological research and diagnostic...
The National Institutes of Health National Center for Advancing Translational Sciences awarded a firm-fixed price purchase order to Promega Corporation for $24,640.20 to supply 18 units of Promega CellTiter-Glo(R) One Solution Assay 500 ml, a one-step, homogenous reagent used to detect ATP levels without additional reagents. The purchase order was awarded non-competitively on March 1, 2024 and delivery is required by March 14, 2024 to support various Early Translation Branch projects at the...
This is a firm fixed-price purchase order awarded by the National Center for Advancing Translational Sciences (NCATS), a civilian agency within the U.S. Department of Health and Human Services. The $86,800.00 contract is for Promega Corporation, a global life sciences company, to provide reagent kits and assays. The award is not set aside for any small business designations. Promega holds several significant federal contract vehicles, including Blanket Purchase Agreements with the Defense Health...